Skip to main content

IRB Committee 2

IRB Committee 2 is responsible for the full review of human subjects research protocols for the C.T. Bauer School of Business, the College of the Arts, and the College of Liberal Arts and Social Sciences (CLASS), with the exception of the Department of Health and Human Performance. IRB 2 does not review FDA-regulated research. 

Full Committee

Submission Deadlines IRB 2 Meeting Date
Friday, August 11, 2017 Friday, August 25, 2017
Friday, September 8, 2017 Friday, September 22, 2017
Friday, October 13, 2017 Friday, October 27, 2017
Friday, November 3, 2017 Friday, November 17, 2017
Wednesday, November 22, 2017 Friday, December 8, 2017
Friday, January 12, 2018 Friday, January 26, 2018
Friday, February 9, 2018 Friday, February 23, 2018
Thursday, March 15, 2018 Friday, March 30, 2018
Friday, April 13, 2018 Friday, April 27, 2018
Friday, May 11, 2018 Friday, May 25, 2018
Friday, June 8, 2018 Friday, June 22, 2018
Friday, July 13, 2018 Friday, July 27, 2018
Friday, August 10, 2018 Friday, August 24, 2018

*Dates are subject to change without notice if circumstances require rescheduling.

Expedited Review

Protocols falling under an expedited category and involving no more than minimal risk, as well as minor changes in approved full board protocols, may be reviewed under an expedited process. The Chair of IRB 2 either reviews or delegates the review to one or more experienced IRB members, who review the protocol under applicable regulations and either approves or requires modifications to the protocol prior to approval. An expedited reviewer may not disapprove a protocol, but may forward to the fully convened committee for further determination if warranted. Expedited submissions are considered on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.  

Exempt Status

Protocols falling under an exempt category defined under the federal regulations require administrative review by the IRB office to ensure that basic ethical principles, such as confidentiality of data and obtaining informed consent where applicable, are addressed. Applications for exempt protocols are reviewed by IRB staff on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.